Research programme: calcium channel antagonists - Ajinomoto

Drug Profile

Research programme: calcium channel antagonists - Ajinomoto

Alternative Names: AGS 1164; APJ 2708; APJ 2929

Latest Information Update: 11 Oct 2010

Price : $50

At a glance

  • Originator Ajinomoto
  • Class Dihydropyridines
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Preclinical Neuropathic pain

Most Recent Events

  • 09 Sep 2010 Preclinical development is ongoing in Japan
  • 04 Sep 2008 Preclinical development is ongoing in Japan
  • 28 Apr 2004 A preclinical study presented at the 33rd Annual Meeting of the Society for Neuroscience (SfN-2003) has been added to the Pain pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top